Relmada Therapeutics, Inc. - RLMD
CFO
Chief Financial Officer
Direct Buys
6
$246,909
253,432
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
0
$0
0
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
05/20/2025
|
05/20/2025 |
Buy
|
60,000 @ $0.52
|
$31,422 | 288,335 (26.28%) | Direct |
|
05/19/2025
|
05/20/2025 |
Buy
|
90,000 @ $0.49
|
$43,686 | 228,335 (65.06%) | Direct |
|
05/16/2025
|
05/20/2025 |
Buy
|
50,000 @ $0.44
|
$22,100 | 138,335 (56.60%) | Direct |
|
09/11/2024
|
09/11/2024 |
Buy
|
24,120 @ $2.95
|
$71,154 | 88,335 (37.56%) | Direct |
|
09/10/2024
|
09/11/2024 |
Buy
|
21,118 @ $2.73
|
$57,652 | 64,215 (49.00%) | Direct |
|
09/09/2024
|
09/11/2024 |
Buy
|
8,194 @ $2.55
|
$20,895 | 43,097 (23.48%) | Direct |